Elsevier

Biochemical Pharmacology

Volume 44, Issue 2, 22 July 1992, Pages 275-283
Biochemical Pharmacology

Effect of age and gender on the activity of human hepatic CYP3A

https://doi.org/10.1016/0006-2952(92)90010-GGet rights and content

Abstract

Many pharmacokinetic investigations in the elderly population reveal decreased clearance of lipophilic drugs metabolized by the cytochrome P450 enzymes; however, few studies have evaluated aging-dependent or gender-related changes in specific cytochrome P450 enzymes. The clearance of quinidine, midazolam, triazolam, erythromycin, and lidocaine declines with age; these drugs are metabolized by the isoform, CYP3A. To determine whether these metabolic effects are due to changes in CYP3A, the effects of age and gender on CYP3A activity were examined. The activity of the human hepatic cytochrome P450, CYP3A, was quantified in vitro as erythromycin N-demethylation in microsomes prepared from forty-three resected human liver specimens obtained from patients, age 27 to 83, with normal liver function. Erythromycin N-demethylation varied 5-fold in human liver microsomes. CYP3A activity was 24% higher in females than males (P = 0.027). CYP3A activity did not correlate with age, smoking status, ethanol consumption or percent ideal body weight. Large interindividual differences and a small female-specific increase in CYP3A activity were obtained. However, CYP3A activity was unaffected by age over the range of 27–83 years, suggesting that the aging-related alteration in the clearance of CYP3A substrates is secondary to changes in liver blood flow, size, or drug binding and distribution with aging.

References (56)

  • MS Anderson et al.

    American Medical Association White paper on Elderly Health

    Arch Intern Med

    (1990)
  • World Health Organization

    Health care in the elderly: Report on the technical group on use of medicaments by the elderly

    Drugs

    (1979)
  • DJ Greenblatt et al.

    Drug disposition in old age

    N Engl J Med

    (1982.)
  • RF Vestal

    Pharmacology and Aging

    J Am Geriatr Soc

    (1982)
  • DJ Greenblatt et al.

    Pharmacokinetic aspects of drug therapy in the elderly

    Ther Drug Monit

    (1986)
  • DP Richey et al.

    Pharmacokinetic consequences of aging

    Annu Rev Pharmacol Toxicol

    (1977)
  • SC Montamat et al.

    Management of drug therapy in the elderly

    N Engl J Med

    (1989)
  • PB Watkins

    Role of cytochromes P450 in drug metabolism and hepatotoxicity

    Semin Liver Dis

    (1990)
  • DW Nebert et al.

    The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature

    DNA Cell Biol

    (1991)
  • DJ Greenblatt et al.

    Age, sex, and nitrazepam kinetics: Relation to antipyrine disposition

    Clin Pharmacol Ther

    (1985)
  • DJ Greenblatt et al.

    Antipyrine kinetics in the elderly: Prediction of age-related changes in benzodiazepine oxidizing capacity

    J Pharmacol Exp Ther

    (1982)
  • DR Abernethy et al.

    Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients

    Ann Intern Med

    (1986)
  • JW Dundee et al.

    The influence of age on the onset of anaesthesia with midazolam

    Anaesthesia

    (1985)
  • B Bach et al.

    Disposition of antipyrine and phenytoin correlated with age and liver volume in man

    Clin Pharmacokinet

    (1981)
  • PB Watkins et al.

    Identification of an inducible form of cytochrome P-450 in human liver

  • SA Wrighton et al.

    Studies on the expression and metabolic capabilities of human liver cytochrome P-450IIIA5 (HLp3)

    Mol Pharmacol

    (1990)
  • FJ Gonzalez et al.

    Human P450PCN1: Sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase

    DNA

    (1988)
  • DT Molowa et al.

    Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver

    • Cited by (0)

    View full text
    Copyright © 1992 Published by Elsevier Inc.